Medplus Health Services
add_icon

Medplus Health Services

819.85
-12.65
(-1.52%)
Market Cap
9,823.65 Cr
PE Ratio
50.94
Volume
55,153.00
Day High - Low
830.00 - 812.00
52W High-Low
1,045.30 - 642.00
ann
There are new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
9,823.65 Cr
EPS
12.57
PE Ratio
50.94
PB Ratio
5.39
Book Value
153.98
EBITDA
535.70
Dividend Yield
0.00 %
Industry
Retail
Return on Equity
8.63
Debt to Equity
0.64
Analyst Rating and Forecast
- By Refinitiv from6 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
negative
MedPlus Health Services subsidiary Optival Health Solutions receives one-day drug license suspension for Karnataka store, resulting in potential revenue loss of ₹0.23 lacs.
negative
MedPlus Health Services subsidiary Optival Health Solutions receives suspension order for Andhra Pradesh store under Drugs and Cosmetics Act, with potential revenue loss of ₹2.10 lakhs.
negative
Medplus Health Services subsidiary encounters drug license suspension in Andhra Pradesh, with company projecting minimal revenue impact of ₹2.10 lakhs from the regulatory action.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
819.85
#1 9,823.65
#3 50.94
#1 6,184.70
#3 9.18
#1 150
#1 43.41
55.36
1,193.10
5,191.29
37.83
5,135.30
30.45
107
40.77
74.46
42.00
82.02
#1 17.22
117.90
#1 99.16
5
-
40.67
59.50
60.62
-
9.20
-4.17
-2
-166.67
50.64
Growth Rate
Revenue Growth
9.18 %
Net Income Growth
128.96 %
Cash Flow Change
275.98 %
ROE
107.45 %
ROCE
49.93 %
EBITDA Margin (Avg.)
24.43 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
810
810
959
932
941
979
1,004
1,132
1,202
1,267
1,294
1,419
1,451
1,501
1,498
1,588
1,574
1,525
1,558
1,697
Expenses
743
745
859
863
872
914
941
1,061
1,119
1,171
1,213
1,324
1,350
1,385
1,395
1,452
1,429
1,373
1,412
1,531
EBITDA
67
65
101
69
69
65
63
71
83
95
81
96
102
116
103
136
145
152
146
166
Operating Profit %
7 %
7 %
10 %
7 %
7 %
5 %
5 %
5 %
6 %
7 %
6 %
6 %
6 %
7 %
6 %
8 %
8 %
9 %
8 %
9 %
Depreciation
22
24
27
28
31
34
38
42
46
56
52
56
57
59
60
63
63
64
66
69
Interest
13
15
15
16
17
19
20
20
21
22
23
24
25
25
25
25
26
27
27
29
Profit Before Tax
32
26
58
25
22
13
5
9
16
17
5
16
20
32
18
48
57
61
53
69
Tax
9
8
12
5
5
1
1
2
3
-9
1
2
6
-2
4
9
11
10
10
13
Net Profit
23
18
46
20
17
11
4
7
13
27
4
15
14
34
14
39
46
51
42
56
EPS in ₹
2.21
1.76
4.34
1.85
1.53
0.99
0.27
0.55
1.12
2.24
0.32
1.22
1.15
2.81
1.20
3.24
3.84
4.32
3.54
4.63

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
438
509
538
644
673
1,349
1,566
2,594
2,797
3,005
3,360
Fixed Assets
67
77
81
84
90
420
517
799
1,138
1,242
1,296
Current Assets
317
376
397
458
475
816
923
1,632
1,481
1,568
1,844
Capital Work in Progress
3
4
0
1
1
5
6
20
26
11
16
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
368
429
457
560
582
924
1,043
1,775
1,633
1,752
2,047
Total Liabilities
438
509
538
644
673
1,349
1,566
2,594
2,797
3,005
3,360
Current Liabilities
210
269
278
326
337
481
415
559
477
526
577
Non Current Liabilities
74
91
111
15
11
339
420
618
830
902
1,044
Total Equity
154
150
149
304
325
529
731
1,417
1,491
1,577
1,740
Reserve & Surplus
141
137
149
303
325
528
359
1,394
1,467
1,554
1,717
Share Capital
12
12
0
0
0
0
0
24
24
24
24

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
32
-15
-10
14
45
56
-37
-93
350
-137
-5
Investing Activities
-16
-32
-15
-18
-19
-28
-35
-703
429
-83
-318
Operating Activities
-19
-17
34
32
147
-7
3
170
90
144
540
Financing Activities
67
35
-29
-1
-83
90
-6
440
-170
-198
-228

Share Holding

% Holding
Aug 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
96.68 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.41 %
40.45 %
40.39 %
40.39 %
40.39 %
40.39 %
40.34 %
40.32 %
40.29 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
12.36 %
0.00 %
14.94 %
14.85 %
14.72 %
15.23 %
15.61 %
16.42 %
16.54 %
DIIs
0.00 %
11.61 %
11.99 %
14.96 %
14.31 %
28.77 %
28.16 %
13.62 %
25.49 %
16.28 %
22.47 %
22.17 %
27.97 %
25.65 %
26.19 %
26.04 %
26.52 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
6.38 %
5.83 %
5.88 %
6.22 %
6.21 %
6.13 %
5.83 %
6.40 %
6.15 %
7.30 %
7.56 %
11.84 %
13.21 %
13.10 %
12.59 %
12.22 %
Others
3.32 %
41.58 %
41.75 %
38.73 %
39.05 %
24.59 %
25.28 %
40.12 %
15.33 %
37.12 %
14.90 %
15.03 %
5.07 %
5.52 %
4.77 %
4.64 %
4.43 %
No of Share Holders
69
3,42,917
82,627
77,119
76,972
74,702
73,512
70,017
66,430
66,048
74,976
76,934
87,328
83,912
83,439
81,742
78,337

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 Dec 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
15 Dec 2023 813.50 734.65
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 682.10 689.45
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 650.80 674.95
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 847.90 730.65
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 732.15 977.00
02 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Aug 2025 853.60 915.25
15 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
15 Sept 2025 915.25 838.75
31 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Oct 2025 757.45 757.85

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20181 day ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20153 days ago
Board Meeting Intimation for Consider & Approve Un-Audited Financial Result For The Quarter Ended December 31 20253 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20155 days ago
Disclosure Under Regulation 31 Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 20116 days ago
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.6 days ago
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.6 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20156 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20118 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 24, 2025
Closure of Trading WindowDec 22, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 20, 2025
Disclosure Under Regulation 31 Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011Dec 19, 2025
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Dec 19, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Dec 19, 2025
Disclosure under Regulation 30A of LODRDec 18, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 14, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 11, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Dec 11, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 10, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 07, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 06, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 04, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 30, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 29, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 27, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 25, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 22, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 21, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 20, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 12, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 04, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 02, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 01, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 01, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 31, 2025
Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025Oct 31, 2025
Board Meeting Outcome for Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025Oct 31, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 25, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 22, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 19, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 15, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 14, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 11, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 10, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
SBI ELSS Tax Saver Fund Direct-Growth
0.00%
-4365417
-1.09%
-1.05%
Nippon India Pharma Fund Direct-Growth
0.00%
-3627277
-3.47%
-3.32%
Kotak Small Cap Fund Direct-Growth
0.00%
-3578425
-1.66%
-1.51%
Nippon India Multi Cap Fund Direct-Growth
0.00%
-2527912
-0.41%
-0.39%
Franklin India Small Cap Fund Direct-Growth
0.00%
-2432539
-1.45%
-1.35%
Nippon India Focused Fund Direct-Growth
0.00%
-2098553
-1.91%
-1.84%
Franklin India Flexi Cap Fund Direct-Growth
0.00%
-1345795
-0.54%
-0.44%
Invesco India Contra Fund Direct-Growth
0.00%
-1094617
-0.43%
-0.41%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.00%
-1071084
-1.34%
-1.23%
SBI Healthcare Opportunities Fund Direct Plan-Growth
0.00%
-500000
-0.98%
-0.93%
Nippon India Flexi Cap Fund Direct - Growth
0.00%
-450000
-0.38%
-0.36%
Bandhan Small Cap Fund Direct-Growth
0.00%
-424694
-0.19%
-0.17%
Kotak Pioneer Fund Direct - Growth
0.00%
-393797
-0.96%
-0.91%
Franklin India Multi Asset Allocation Fund Direct-Growth
0.00%
-291365
-1.02%
0.00%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.00%
-247579
-0.75%
-0.69%
DSP Healthcare Fund Direct - Growth
0.00%
-192078
-0.49%
-0.47%
Nippon India Multi Asset Allocation Fund Direct - Growth
0.00%
-182368
-0.15%
-0.16%
Nippon India Aggressive Hybrid Fund Direct-Growth
0.00%
-167620
-0.33%
-0.31%
Quant Consumption Fund Direct - Growth
0.00%
-143928
-5.33%
-6.89%
Bandhan Balanced Advantage Fund Direct-Growth
0.00%
-134101
-0.47%
-0.45%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-130000
-1.72%
-1.41%
Franklin India ELSS Tax Saver Fund Direct-Growth
0.00%
-128560
-0.15%
-0.14%
Bajaj Finserv Small Cap Fund Direct-Growth
0.00%
-118997
-0.63%
-0.60%
Bajaj Finserv Healthcare Fund Direct-Growth
0.00%
-51652
-1.23%
-1.17%
Unifi Flexi Cap Fund Direct-Growth
0.00%
-20002
-0.99%
-0.98%

Technical Indicators

RSI(14)
Neutral
62.86
ATR(14)
Volatile
22.36
STOCH(9,6)
Neutral
53.10
STOCH RSI(14)
Neutral
44.70
MACD(12,26)
Bearish
-0.21
ADX(14)
Weak Trend
17.77
UO(9)
Bearish
63.20
ROC(12)
Uptrend And Accelerating
3.92
WillR(14)
Neutral
-22.69